Healthcare - Biotechnology - NASDAQ - US
$ 24.05
-8.59 %
$ 1.99 B
Market Cap
-15.22
P/E
BALANCE SHEET
1.46 B
ASSETS
478 M
LIABILITIES
981 M
EQUITY
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition
Beam Therapeutics Inc.
| Current Assets | 1.21 B |
| Cash & Short-Term Investments | 1.19 B |
| Receivables | 0 |
| Other Current Assets | 21.2 M |
| Non-Current Assets | 249 M |
| Long-Term Investments | 0 |
| PP&E | 238 M |
| Other Non-Current Assets | 10.9 M |
| Current Liabilities | 206 M |
| Accounts Payable | 1.62 M |
| Short-Term Debt | 13.3 M |
| Other Current Liabilities | 191 M |
| Non-Current Liabilities | 273 M |
| Long-Term Debt | 160 M |
| Other Non-Current Liabilities | 113 M |
Balance Sheet
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Cash & Cash Equivalents | 435.9 | 232.8 | 965.6 | 162.2 | 37.2 | 146.4 | 1.9 |
| Short Term Investments | 754.0 | 845.4 | 405.7 | 137.5 | 54.6 | 0 | 0 |
| Receivables | 0 | 0 | 300.0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | (607.4) | 0 | 0 | 0 | 0 |
| Other Current Assets | 21.2 | 14.8 | 7.4 | 17.3 | 5.4 | 1.8 | 0.1 |
| Total Current Assets | 1 211.0 | 1 092.9 | 965.6 | 308.3 | 94.5 | 148.3 | 2.0 |
| PP&E | 237.8 | 234.1 | 187.0 | 125.4 | 43.2 | 16.9 | 0.3 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments | 0 | 12.8 | 12.7 | 14.8 | 13.3 | 1.5 | 30 K |
| Other Long Term Assets | 10.9 | 1.9 | 309.1 | 3.1 | 5.0 | 0.3 | 0 |
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 1 459.7 | 1 341.7 | 1 474.5 | 451.7 | 156.1 | 167.0 | 2.4 |
| LIABILITIES | |||||||
| Accounts Payable | 1.6 | 9.0 | 7.5 | 6.3 | 7.8 | 7.4 | 0.7 |
| Short Term Debt | 13.3 | 12.2 | 9.8 | 4.2 | 4.3 | 0 | 1.0 |
| Other Current Liabilities | 122.5 | 68.2 | 112.2 | 91.8 | 17.0 | 18.2 | 4.8 |
| Total Current Liabilities | 205.6 | 223.6 | 213.4 | 102.3 | 29.1 | 25.6 | 6.6 |
| Long Term Debt | 159.9 | 168.6 | 134.8 | 96.0 | 21.2 | 0 | 0 |
| Deferred Tax Income | 0 | 0 | 0 | (0.4) | 0 | 0 | 0 |
| Other Liabilities | 3.0 | 13.8 | 37.2 | 7.8 | 4.8 | 7.4 | 20 K |
| Total Liabilities | 478.4 | 608.2 | 647.7 | 206.1 | 55.2 | 33.0 | 6.6 |
| EQUITY | |||||||
| Common Stock | 0.8 | 0.7 | 0.7 | 0.6 | 73 K | 56 K | 5 K |
| Retained Earnings | (1 189.9) | (1 057.4) | (768.3) | (397.6) | (203.0) | (124.7) | (9.5) |
| Other Accumulative Comprehensive Income/Loss | 0.6 | (2.4) | 50 K | 9 K | 16 K | (0.7) | 11 K |
| Total Equity | 981.3 | 733.5 | 826.7 | 245.6 | 100.9 | 134.0 | (4.2) |
| Total Liabilities and Equity | 1 459.7 | 1 341.7 | 1 474.5 | 451.7 | 156.1 | 167.0 | 2.4 |
| SHARES OUTSTANDING | |||||||
| Common Shares Outstanding | 77.2 | 70.0 | 64.2 | 46.7 | 51.3 | 35.1 | 13.0 |